NCLEX Questions on Drug Classifications Related

Review NCLEX Questions on Drug Classifications related questions and content

When patients are started on darbepoetin alfa (Aranesp) they need monitoring of their blood counts to determine a dosage adjustment in:

  • A. 6 weeks if they are a cancer patient
  • B. 1 week if they have chronic renal failure
  • C. 2 weeks if they are taking it for allogenic transfusion
  • D. Each week throughout therapy
Correct Answer: A

Rationale: Cancer patients need blood count checks at 6 weeks for darbepoetin adjustment; renal patients adjust sooner, typically 2-4 weeks.